Abstract
The autoinhibitory control of electrically evoked release of [3H]-dopamine and the properties of that induced by nicotinic receptor (nAChR) stimulation were studied in slices of the human neocortex. In both models [3H]-dopamine release was action potential-induced and exocytotic. The selective dopamine D2 receptor agonist (-)-quinpirole reduced electrically evoked release of [3H]-dopamine, yielding IC50 and I(max) values of 23 nM and 76%, respectively. Also, the effects of several other subtype-selective dopamine receptor ligands confirmed that the terminal dopamine autoreceptor belongs to the D2 subtype. The autoinhibitory feedback control was slightly operative under stimulation conditions of 90 pulses and 3 Hz, with a biophase concentration of endogenous dopamine of 3.6 nM, and was enhanced under blockade of dopamine reuptake. [3H]-dopamine release evoked in an identical manner in mouse neocortical slices was not inhibited by (-)-quinpirole, suggesting the absence of dopamine autoreceptors in this tissue and underlining an important species difference. Also, nAChR stimulation-induced release of [3H]-dopamine revealed a species difference: [3H]-dopamine release was evoked in human, but not in rat neocortical slices. The nAChRs inducing [3H]-dopamine release most probably belong to the alpha3/beta2subtype, according to the potencies and efficacies of subtype-selective nAChR ligands. Part of these receptors may be located on glutamatergic neurons.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / analogs & derivatives
-
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / pharmacology
-
Adolescent
-
Adult
-
Aged
-
Alkaloids / pharmacology
-
Analysis of Variance
-
Animals
-
Autoreceptors / physiology*
-
Azocines / pharmacology
-
Calcium / pharmacology
-
Child
-
Child, Preschool
-
Domperidone / pharmacology
-
Dopamine / metabolism*
-
Dopamine Antagonists / pharmacology
-
Dose-Response Relationship, Drug
-
Drug Interactions
-
Electric Stimulation / methods
-
Feedback / drug effects
-
Female
-
Fluvoxamine / pharmacology
-
Humans
-
In Vitro Techniques
-
Isoxazoles / pharmacology
-
Male
-
Maprotiline / analogs & derivatives
-
Maprotiline / pharmacology
-
Mice
-
Middle Aged
-
Neocortex / drug effects
-
Neocortex / metabolism*
-
Neocortex / radiation effects
-
Nicotine / pharmacology
-
Nicotinic Antagonists / pharmacology
-
Potassium / pharmacology
-
Pyrrolidines / pharmacology
-
Quinolizines / pharmacology
-
Rats
-
Receptors, Nicotinic / physiology*
-
Sulpiride / pharmacology
-
Time Factors
-
Tritium / metabolism
Substances
-
Alkaloids
-
Autoreceptors
-
Azocines
-
Dopamine Antagonists
-
Isoxazoles
-
Nicotinic Antagonists
-
Pyrrolidines
-
Quinolizines
-
Receptors, Nicotinic
-
Tritium
-
3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole
-
1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine
-
Maprotiline
-
hydroxymaprotilin
-
cytisine
-
Domperidone
-
Nicotine
-
Sulpiride
-
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
-
Fluvoxamine
-
Potassium
-
Calcium
-
Dopamine